Transwell and Boyden assays indicated that inhibition of Bmi-1 reduced the migratory/invasive phenotype of Hes1-expressing colon cancer cells (Figure 7C), which was confirmed by in vivo experiments (Figure 7F). This evidence concerns the gene HES1 and colonic neoplasm.